Related references
Note: Only part of the references are listed.Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
Youn Ho Shin et al.
LANCET RHEUMATOLOGY (2021)
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Giuseppe Lippi et al.
CLINICA CHIMICA ACTA (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Immunology of COVID-19: Current State of the Science
Nicolas Vabret et al.
IMMUNITY (2020)
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Tobias Herold et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Elevated interleukin-6 and severe COVID-19: A meta-analysis
Muhammad Aziz et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
Yong Gao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
Wen Wen et al.
CELL DISCOVERY (2020)
Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis
Milos Jesenak et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Procalcitonin levels in COVID-19 patients
Rui Hu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
Jee Myung Yang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Interleukin-6 as prognosticator in patients with COVID-19
Elisa Grifoni et al.
JOURNAL OF INFECTION (2020)
From C-Reactive Protein to Interleukin-6 to Interleukin-1 Moving Upstream To Identify Novel Targets for Atheroprotection
Paul M. Ridker
CIRCULATION RESEARCH (2016)
Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting
W. C. Albrich et al.
INTENSIVE CARE MEDICINE (2015)
Cytokines and Chemokines as Biomarkers of Community-Acquired Bacterial Infection
Michal Holub et al.
MEDIATORS OF INFLAMMATION (2013)
Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome
Pierre Emmanuel Charles et al.
CRITICAL CARE (2009)
Share Paper
